https://www.selleckchem.com/pr....oducts/glutaraldehyd
This study supports the epidemiological observations and adds a causal explanation for the health promoting effects of the most common biopolymer on earth. Programmed cell death protein 1 (PD-1) inhibitors are the first-line treatment for advanced non-small-cell lung cancer (NSCLC) patients. However, their efficacy in metastatic NSCLC patients remains controversial. The aim of our study was to evaluate the prognosis of advanced metastatic NSCLC patients treated with PD-1 inhibitors, and discuss the predictive effect of metastatic
Like
Comment
Share
